BYRN
Byrna Technologies Inc.
BYRN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT
Caterpillar Inc.
CAT has the edge over BYRN overall, supported by stronger fundamentals and lower modeled downside.
BYRN Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Healthy | |
| Strong |
BYRN's cash flow and balance sheet are currently healthy, but its revenue and profitability are weak.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
BYRN PE Valuation
BYRN has no meaningful PE right now: it lost money over the past year.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
BYRN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect BYRN's losses to grow, with revenue declining.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over BYRN on the outlook, with more favorable earnings and revenue expectations.
BYRN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | -159% |
| Q2 2026 | -$0.18 | -129% |
| Q1 2026 | $0.36 | -42% |
| Q4 2025 | $0.40 | -27% |
| Q3 2025 | $0.68 | +656% |
| Q2 2025 | $0.63 | +$0.77 |
| Q1 2025 | $0.62 | +$0.90 |
| Q4 2024 | $0.55 | +$0.93 |
BYRN has swung to a loss: it lost $0.40 per share over the past year, after a profit the year before.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over BYRN on earnings quality, reporting a profit while its opponent remains loss making.
BYRN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $15.3M | -46% |
| Q2 2026 | $16.4M | -43% |
| Q1 2026 | $29M | +11% |
| Q4 2025 | $35.2M | +26% |
| Q3 2025 | $28.2M | +35% |
| Q2 2025 | $28.5M | +41% |
| Q1 2025 | $26.2M | +57% |
| Q4 2024 | $28M | +79% |
BYRN has the edge over CAT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -19% | -29 points |
| Q2 2026 | -78% | -90 points |
| Q1 2026 | 3.2% | -3.3 points |
| Q4 2025 | 11% | -3.4 points |
| Q3 2025 | 10% | +6.2 points |
| Q2 2025 | 12% | +2.2 points |
| Q1 2025 | 6.5% | +7.5 points |
| Q4 2024 | 15% | +20 points |
BYRN's operating margin was −19% last quarter, down 29 points from the same quarter a year ago.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over BYRN on profitability, with a higher operating margin.
BYRN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$538K | +$4M |
| Q2 2026 | $876K | +$7.3M |
| Q1 2026 | -$5M | +$1.4M |
| Q4 2025 | $8.1M | +29% |
| Q3 2025 | -$4.5M | -$2.4M |
| Q2 2025 | -$6.4M | -553% |
| Q1 2025 | -$6.4M | -270% |
| Q4 2024 | $6.3M | -9.5% |
BYRN's free cash flow has turned positive again: $3M over the past year, against −$11M the year before.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
BYRN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.3% | +294K shares |
| 1 year | -4.7% | -1.1M shares |
| 3 years | +4.6% | +1M shares |
| 5 years | +4.2% | +934K shares |
| Available history | +122% | +12.6M shares |
BYRN has the edge over CAT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $953,000 |
| Q4 2025 | $1M |
| Q3 2025 | — |
| Q4 2024 | $506,000 |
| Q3 2024 | $3M |
| Q3 2023 | — |
BYRN spent $2M buying back its own shares over the past year.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has 461M diluted shares, down 2.1% from a year ago, with $8.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
BYRN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -2.1x | Net Cash |
| Q3 2024 | -6.4x | Net Cash |
| Q2 2021 | -31.3x | Net Cash |
BYRN has more cash than debt.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
BYRN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 36.9 | Neutral |
BYRN's weekly RSI is 38 (neutral) and its Stochastic is 37 (neutral).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BYRN PE vs Industrials Sector
| Metric | BYRN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
BYRN has no meaningful PE right now: it lost money over the past year.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
BYRN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.14 | 7% below |
| 20 week MA | $4.12 | 6.6% below |
| 50 week MA | $8.13 | 53% below |
| 100 week MA | $16.0 | 76% below |
| 200 week MA | $12.6 | 69% below |
BYRN is in a downtrend: it's below all five of its weekly moving averages, and 69% below its 200-week average.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over BYRN on trend strength, trading above more of its moving averages.
BYRN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.90 | $14.9 | +684% |
| 2021 | $14.9 | $14.0 | -6.1% |
| 2022 | $14.0 | $8.10 | -42% |
| 2023 | $8.10 | $6.39 | -21% |
| 2024 | $6.39 | $30.1 | +370% |
| 2025 | $30.1 | $16.7 | -44% |
| 2026 YTD | $16.7 | $3.85 | -77% |
BYRN's yearly returns have swung widely, from +684% in 2020 to −44% in 2025. It's down 77% so far in 2026.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over BYRN on returns for 2026, with the stronger performance.